First BanCorp (FBP) Faces Lawsuit Questions On A Valuation That Already Looks Full
First Bancorp FBP | 0.00 |
Legal action puts fresh focus on First BanCorp stock
First BanCorp (NYSE:FBP) is in the spotlight after investors digested news of a lawsuit in the Southern District of New York related to banking services for Jeffrey Epstein, following a U.S. Virgin Islands acquisition.
The legal headlines arrive after a strong run in First BanCorp’s stock, with a 30 day share price return of 8.96% and a 90 day share price return of 21.73%. The 1 year total shareholder return of 26.86% and 5 year total shareholder return of 163.57% point to momentum that has been building over time.
If this legal case has you reassessing where risk and opportunity lie in your portfolio, it could be a good moment to widen your search and check out 20 top founder-led companies
After that run and with a fresh legal overhang in play, the balance between risk and upside in First BanCorp looks less straightforward. How does the current valuation compare with the fundamentals investors are paying for today?
Most Popular Narrative: 2% Overvalued
Against a last close of $26.50 for First BanCorp, the most widely followed narrative points to a fair value of $26.00, so only a small gap exists between price and model.
The analysts have a consensus price target of $26.0 for First BanCorp based on their expectations of its future earnings growth, profit margins and other risk factors. In order for you to agree with the analysts, you would need to believe that by 2029, revenues will be $1.2 billion, earnings will come to $348.0 million, and it would be trading on a PE ratio of 12.6x, assuming you use a discount rate of 7.1%.
Want to see what really underpins that $26.00 fair value for First BanCorp? The narrative leans heavily on specific revenue, margin and earnings assumptions, plus a future valuation multiple that is meaningfully above today. Curious which combination of these inputs is doing the heavy lifting in the model?
Result: Fair Value of $26.00 (OVERVALUED)
However, the First BanCorp narrative could be tested if its geographic concentration in Puerto Rico is exposed to a local shock, or if higher regulatory and compliance costs reduce profitability.
Another View on First BanCorp’s Value
The analyst narrative suggests First BanCorp is about 2% overvalued at a fair value of $26.00, yet our DCF model points in a different direction. On this approach, the stock at $26.50 trades at a large discount to an estimated future cash flow value of $55.45. This frames the current price as a very different risk reward trade off. Which set of assumptions do you find more convincing?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out First BanCorp for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 41 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment on First BanCorp clearly mixed, this is a moment to move quickly, review the underlying numbers and decide where you stand, especially as the stock carries 2 key rewards and 1 important warning sign
Looking for more ideas beyond First BanCorp?
If this First BanCorp update has sharpened your thinking, do not stop here. Use the Simply Wall St screener to spot other stocks that could fit your goals.
- Target steadier compounding potential by reviewing companies highlighted in the 74 resilient stocks with low risk scores.
- Hunt for quality at a sensible price by scanning the screener containing 18 high quality undiscovered gems before they get crowded.
- Focus on financial strength first by filtering for businesses in the solid balance sheet and fundamentals stocks screener (47 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
